Resources
Explore our growing body of resources and research from across the women’s health innovation ecosystem.
Explore
2024
Organoid modeling meets cancers of female reproductive tract.
Li et al.
Reviews organoid models for female reproductive tract cancers, summarizing construction methods, research advances, limitations, and future applications in personalized medicine and drug development.
2010
Pessary Use in Pelvic Organ Prolapse and Urinary Incontinence
Jones, K. A. & Harmanli, O.
Provides information on pessary types, indications, fitting, maintenance, and complications for managing pelvic organ prolapse and urinary incontinence.
2025
R&D funding landscape for endometriosis
Impact Global Health
Summarizes global R&D funding, diagnostic and treatment pipelines, and unmet needs for endometriosis to inform research, policy, and investment decisions.
2025
R&D funding landscape for menopause
Impact Global Health
Summarizes menopause R&D needs, current treatments, funding data, and innovation gaps to inform funders, policymakers, and advocates on advancing menopause care and research.
2023
Reproductive Health Impact Study
Guttmacher
Provides data and analysis on how federal and state policy changes affect US publicly funded family planning care, aiming to inform policy and improve reproductive health equity.
2025
Research & Development Landscape for Maternal Enteric Microbiome Medicines (2000-2023)
Impact Global Health
Summarizes global research and development trends for maternal enteric microbiome medicines (2000-2023) to guide future maternal and neonatal health interventions.
2025
Research & Development Landscape for Maternal Iron Deficiency Anaemia Medicines (2000-2023)
Impact Global Health
Reviews research and development data on maternal iron deficiency anaemia medicines (2000-2023) to inform innovation, policy decisions, and future investment priorities.
2024
Research advances in the construction of stem cell-derived ovarian organoids
Zhang et al.
Reviews advances in constructing stem cell-derived ovarian organoids, summarizing methods, challenges, and applications for reproductive medicine and fertility preservation.
2023
Small Vulnerable Newborn Series
The Lancet
Summarizes prevalence, risks, mechanisms, and prevention strategies for small vulnerable newborns to inform global health action and improve outcomes.
2025
Snapshot of the R&D Landscape for Pre-eclampsia
Impact Global Health
Summarizes the current R&D landscape for pre-eclampsia, including medicines, diagnostics, funding, and innovation priorities, to inform research, policy, and advocacy decisions.
2025
Snapshot of the R&D landscape of postpartum haemorrhage devices (2000-2023)
Impact Global Health
Summarizes the R&D landscape, pipeline status, and types of postpartum haemorrhage devices from 2000-2023 to inform innovation and investment decisions.
2016
The Direct and Indirect Costs Associated with Endometriosis: A Systematic Literature Review
Soliman, A. M. et al.
Summarizes direct and indirect costs of endometriosis worldwide to inform understanding of its economic burden for healthcare planning and policy.
2024
The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial
WOMAN-2 Trial Collaborators
Provides information on the WOMAN-2 trial, which evaluated whether tranexamic acid prevents postpartum haemorrhage in anaemic women; found no benefit.
2024
The effect of UNIMMAP multiple micronutrient supplements versus iron-folic acid and placebo in anemia reduction among women of reproductive age in Kebribeyah Woreda, Somali Regional State, Ethiopia: a study protocol for a community-based individual RCT
Kuche et al.
Provides information on a randomized trial protocol comparing UNIMMAP-MMS, iron-folic acid, and placebo for reducing anemia in Ethiopian women of reproductive age.
2015
The Epidemiology of Global Micronutrient Deficiencies
Bailey, R. L. et al.
Summarizes the global epidemiology, causes, consequences, and intervention strategies for micronutrient deficiencies, to inform effective public health actions.
2021
The Missed Disease? Endometriosis As An Example Of ‘Undone Science’
Hudson, N.
Summarizes how endometriosis exemplifies 'undone science,' highlighting its historical neglect, diagnostic challenges, and the marginalization of women's experiences in research and policy.
2020
The New Contraceptive Revolution: Developing Innovative Products Outside of Industry
Callahan, R. et al.
Summarizes challenges, opportunities, and lessons learned for non-industry developers creating innovative contraceptive products outside the pharmaceutical sector.
2017
The Pregnant Women as a Drug Orphan: A Global Survey of Registered Clinical Trials of Pharmacological Interventions in Pregnancy
Scaffidi, J. et al.
Summarizes the global under-representation, funding, and focus areas of registered clinical drug trials in pregnancy to highlight gaps in medication research and development.
We’d love to hear from you.